Arnold & Porter Advises Client, Aptiv Solutions on Its Announced Sale to ICON PLC

March 31, 2014

Washington, D.C., March 31, 2014 -- Arnold & Porter LLP announced today that the firm advised client, Aptiv Solutions, in all aspects of its announced cash sale to ICON plc, including corporate, antitrust, FDA/regulatory and labor and employment issues. The $143.5 million transaction is subject to certain closing conditions.

Headquartered in Reston, Virginia and with 16 operations in 16 countries, Aptiv Solutions is a global CRO in the design and execution of adaptive clinical trials for its pharmaceutical and biotech customers. Its software is used by the FDA, EMA and Japan's PMDA, as well as over fifty top pharmaceutical and medical device companies and academic researchers. Aptiv Solutions is owned by The Halifax Group, SV Life Sciences, Comvest Partners and Management.

ICON plc is based in Dublin, Ireland and a global CRO that provides outsourced development services to the pharmaceutical, biotechnology and medical device industries.

Arnold & Porter's cross-practice, cross-office team advising Aptiv Solutions on the sale was headed by partner Kevin Lavin, head of the firm's Corporate and Securities Group, and New York partner Josh Berick. The firm's legal team also included partners Cynthia Mann and Edward Bintz, and associates Justin Hedge, Catherine Long, Diem-Mi Lu, Charlotte Simphal and Jennifer Tam.

Arnold & Porter LLP is an international law firm of nearly 800 lawyers with offices in Brussels, Denver, Houston, London, Los Angeles, New York, San Francisco, Silicon Valley, and Washington, D. C. The firm, founded in 1946, maintains more than 26 practice areas spanning a broad spectrum of the law, with a primary focus on litigation, transactional matters, and regulatory issues.

Email Disclaimer